| |
|
 |
UPCOMING EVENT |
|
|
| |
|
| |
|
| |
|
Upcoming JAX™ Virtual Seminar:
|
| |
|
Next-generation Models for the PK Evaluation of Antibody and Albumin-Conjugated Drug Candidates
|
| |
|
April 2, 2025 | 4:30 PM CEST | 3:30 PM (BST)
10:30 AM ET (New York)
|
| |
|
|
 |
|
| |
|
|
| |
|
This is your reminder to join our upcoming April 2 virtual symposium to discover how JAX's humanized models deliver superior predictions of biologic drug performance and more accurate preclinical pharmacokinetic data. |
|
|
| |
|
Conventional preclinical models often struggle to effectively evaluate antibody-based therapeutics as they do not reflect crucial aspects of human physiology, forcing drug developers into cautious, complex strategies. JAX's next-generation humanized models solve this by authentically replicating human physiology and pathology. |
|
|
| |
|
Industry experts will showcase how JAX humanized models provide better predictions of biologic drug candidate performance, with equivalent or better predictive ability than nonhuman primates for human pharmacokinetics, in three 20-minute presentations. |
|
|
| |
|
Learn more about the benefits of attending this virtual symposium or register now by clicking the button below. |
|
|
| |
|
|
| |
|
We look forward to your participation in this event! |
|
|
| |
|
Have a Friend or Colleague Who Would Be Interested in this Event? |
|
|
|
|
|
